C-Reactive Protein, Interleukin-6, and Vascular Recurrence After Stroke: An Individual Participant Data Meta-Analysis

医学 狼牙棒 内科学 冲程(发动机) C反应蛋白 相对风险 前瞻性队列研究 心脏病学 置信区间 炎症 心肌梗塞 经皮冠状动脉介入治疗 机械工程 工程类
作者
John Joseph McCabe,Cathal Walsh,Sarah Gorey,Katie Harris,Pablo Hervella,Ramón Iglesias‐Rey,Christina Jern,Linxin Li,Nobukazu Miyamoto,Joan Montaner,Annie Pedersén,Francisco F. Purroy,Peter Malcolm Rothwell,Cathie L. M. Sudlow,Yuji Ueno,Mikel Vicente Pascual,William N. Whiteley,Mark Woodward,Peter J. Kelly
出处
期刊:Stroke [Lippincott Williams & Wilkins]
卷期号:54 (5): 1289-1299 被引量:95
标识
DOI:10.1161/strokeaha.122.040529
摘要

Background: Anti-inflammatory therapies reduce recurrent vascular events in coronary disease. Existing studies have reported highly conflicting findings for the association of blood inflammatory markers with vascular recurrence after stroke leading to uncertainty about the potential of anti-inflammatory therapies after stroke and no consensus about the utility of measurement of inflammatory markers in current guidelines. Methods: We investigated the association between hsCRP (high-sensitivity C-reactive protein), IL-6 (interluekin-6), and recurrent major adverse cardiovascular events (MACE), and stroke from individual participant data from 8420 patients with ischemic stroke/transient ischemic attack from 10 prospective studies. We did within-study multivariable regression analyses and then combined adjusted risk ratio (RR) by random-effects meta-analysis. Results: During 18 920 person-years of follow-up, 1407 (16.7% [95% CI, 15.9–17.5]) patients had MACE and 1191 (14.1% [95% CI, 13.4–14.9]) patients had recurrent stroke. On bivariate analysis, baseline IL-6 was associated with MACE (RR, 1.26 [95% CI, 1.10–1.43]) and recurrent stroke (RR, 1.18 [95% CI, 1.05–1.32]), per unit increase log e IL-6. Similar associations were observed for hsCRP (MACE RR, 1.19 [95% CI, 1.09–1.29]; recurrent stroke RR, 1.12 [95% CI, 1.04–1.21], per unit increase log e hsCRP). After adjustment for vascular risk factors and treatment, independent associations remained with MACE (IL-6, RR, 1.12 [95% CI, 1.04–1.21]; hsCRP, RR, 1.09 [95% CI, 1.04–1.15]) and recurrent stroke (IL-6, RR, 1.09 [95% CI, 1.00–1.19]; hsCRP, RR, 1.05 [95% CI, 1.00–1.11]). Comparing the top with the bottom quarters (Q4 versus Q1), IL-6 (RR, 1.35 [95% CI, 1.09–1.67]) and hsCRP (RR, 1.31 [95% CI, 1.07–1.61]) were associated with MACE after adjustment. Similar results were observed for recurrent stroke for IL-6 (RR, 1.33 [95% CI, 1.08–1.65]) but not hsCRP (RR, 1.16 [95% CI, 0.93–1.43]). Conclusions: Blood markers of inflammation were independently associated with vascular recurrence after stroke, strengthening the rationale for randomized trials of anti-inflammatory therapies for secondary prevention after ischemic stroke/TIA.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
胡萝卜完成签到,获得积分10
1秒前
清秀雁菡完成签到,获得积分10
1秒前
橙梨苹发布了新的文献求助10
1秒前
戴小鱼发布了新的文献求助10
1秒前
浩浩完成签到,获得积分10
1秒前
LONG完成签到 ,获得积分10
2秒前
体贴的青烟完成签到,获得积分10
2秒前
爱喝牛奶的大兔子完成签到,获得积分10
3秒前
Yi完成签到,获得积分10
3秒前
Nice2Cu完成签到,获得积分10
3秒前
4秒前
4秒前
CC完成签到,获得积分10
4秒前
直率十八完成签到,获得积分10
5秒前
赤练仙子完成签到,获得积分10
6秒前
cccc完成签到,获得积分20
6秒前
6秒前
7秒前
Elysia完成签到 ,获得积分10
7秒前
懒洋洋发布了新的文献求助10
7秒前
潇洒凡柔完成签到,获得积分10
7秒前
认真太阳完成签到,获得积分10
7秒前
ccc完成签到,获得积分10
8秒前
水尽云生处完成签到,获得积分10
8秒前
默默毛豆222完成签到 ,获得积分10
8秒前
畅快的胡萝卜完成签到,获得积分10
8秒前
Tasia完成签到 ,获得积分10
8秒前
小黑莓完成签到,获得积分10
8秒前
8秒前
鱼子yuzi完成签到,获得积分10
8秒前
天上的云在飘完成签到,获得积分10
8秒前
森系女孩完成签到,获得积分10
9秒前
QIAN发布了新的文献求助10
9秒前
凶猛的兔子完成签到,获得积分10
10秒前
戴小鱼完成签到,获得积分20
10秒前
沈自耕发布了新的文献求助10
10秒前
DYF完成签到,获得积分10
11秒前
ZMM完成签到,获得积分10
11秒前
11秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180189
求助须知:如何正确求助?哪些是违规求助? 9570320
关于积分的说明 21810161
捐赠科研通 7776320
什么是DOI,文献DOI怎么找? 3433267
关于科研通互助平台的介绍 2557483
邀请新用户注册赠送积分活动 2479039